Fransen Fiona, Melchers Maria J B, Meletiadis Joseph, Mouton Johan W
Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands
Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands.
J Antimicrob Chemother. 2016 Oct;71(10):2883-9. doi: 10.1093/jac/dkw212. Epub 2016 Jun 7.
Although nitrofurantoin has been used for >60 years for the treatment of uncomplicated urinary tract infections, its pharmacodynamic properties are not fully explored. Use is increasing because of increasing resistance to other antimicrobials due to ESBLs.
We tested nine ESBL+ and two ESBL- strains in time-kill assays. Bactericidal activity and regrowth were assessed for all species and concentrations. Early-phase pharmacodynamics was analysed with a sigmoidal Emax model and the maximal killing rate, slope and EC50/MIC ratio were determined for each species.
A bactericidal effect was found at ≥2× MIC for Enterobacter cloacae after 4-8 h, for Klebsiella pneumoniae after 8-10 h and for Escherichia coli after 12-16 h. Overall, no killing was observed at low sub-MIC concentrations, whereas regrowth was found at 0.5-1× MIC after a short decline in cfu. The lowest maximal killing rates were observed for E. coli (0.21 ± 0.05 h(-1)), followed by K. pneumoniae (0.37 ± 0.09 h(-1)) and E. cloacae (0.87 ± 0.01 h(-1)). Surprisingly, the Hill slopes for these three species were significantly different (10.45 ± 9.37, 2.68 ± 0.64 and 1.01 ± 0.06, respectively), indicating a strong concentration-dependent early-phase antibacterial activity against E. cloacae. EC50/MIC ratios were significantly lower for E. coli (0.24 ± 0.08 mg/L) and K. pneumoniae (0.27 ± 0.03 mg/L) as compared with E. cloacae (0.77 ± 0.18 mg/L).
Nitrofurantoin was bactericidal against all species, demonstrating an unusual differential pattern of activity with concentration-dependent-type killing behaviour against E. cloacae and time-dependent killing behaviour against E. coli, which may have significant consequences on species-dependent dosing regimens. The results also demonstrate that the pharmacodynamic properties of some drugs cannot be generalized within a family, here the Enterobacteriaceae.
尽管呋喃妥因已用于治疗非复杂性尿路感染60多年,但其药效学特性尚未得到充分研究。由于超广谱β-内酰胺酶(ESBLs)导致对其他抗菌药物的耐药性增加,其使用正在增多。
我们在时间杀菌试验中测试了9株产ESBLs菌株和2株非产ESBLs菌株。评估了所有菌种和浓度下的杀菌活性及再生长情况。用S形Emax模型分析早期药效学,并确定每种菌种的最大杀菌率、斜率和EC50/MIC比值。
对于阴沟肠杆菌,在4 - 8小时后,≥2×MIC时发现有杀菌作用;对于肺炎克雷伯菌,在8 - 10小时后;对于大肠埃希菌,在12 - 16小时后。总体而言,在低亚MIC浓度下未观察到杀菌作用,而在cfu短暂下降后,在0.5 - 1×MIC时发现有再生长现象。大肠埃希菌的最大杀菌率最低(0.21±0.05 h⁻¹),其次是肺炎克雷伯菌(0.37±0.09 h⁻¹)和阴沟肠杆菌(0.87±0.01 h⁻¹)。令人惊讶的是,这三种菌种的希尔斜率有显著差异(分别为10.45±9.37、2.68±0.64和1.01±0.06),表明对阴沟肠杆菌有很强的浓度依赖性早期抗菌活性。与阴沟肠杆菌(0.77±0.18 mg/L)相比,大肠埃希菌(0.24±0.08 mg/L)和肺炎克雷伯菌(0.27±0.03 mg/L)的EC50/MIC比值显著更低。
呋喃妥因对所有菌种均有杀菌作用,呈现出一种不寻常的差异活性模式,对阴沟肠杆菌具有浓度依赖性杀菌行为,对大肠埃希菌具有时间依赖性杀菌行为,这可能对菌种依赖性给药方案产生重大影响。结果还表明,某些药物的药效学特性在一个菌科(此处为肠杆菌科)内不能一概而论。